NorthWest Biotherapeutics Inc (NWBO)

[Galzus Research]

Oh I for sure know very few of the critics here have read the article, given the kinds of things that I'm being accused of omitting.

Case in point of not bothering to do the most basic research: this pseudonym's first article was from November 2021: https://seekingalpha.com/article/4470668-inovio-pharmaceuticals-high-risk-but-possible-high-reward#source=author_id%3A106409%7Cauthor_slug%3Agalzus-research%7Ccontent_type%3Aall%7Cfirst_level_url%3Aauthor%7Csection_asset%3Aprofile_page_author_analysis%7Csection%3Aprofile_page_author

I was publishing under my real name from around 2014 to 2019, over 500 articles, and learned firsthand what happens when you put your name out there and voice concerns regarding cult stocks.

I will say that, despite the lack of comments on the article, it has reached an unusually high traffic amount relative to other biotech articles. If any of you guys were to actually come in and correct what you find is wrong, or report the article for inaccuracies, these would go a long way toward setting the record straight, or forcing me to, assuming the editorial team deems those criticisms valid.

But it's easier to push the narrative that this article is part of a manipulation scheme and to call for my doxing. Very few critiques of the article, and none so far that has been reasonable. Just "it's a hit piece." And if you think that, I don't think you've ever seen a hit piece.